Laboratory of Lymphocyte Signaling and Oncoproteome

The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL

Vasyutina, E Boucas, JM Bloehdorn, J Aszyk, C Crispatzu, G Stiefelhagen, M Breuer, A Mayer, P Lengerke, C Döhner, H Beutner, D Rosenwald, A Stilgenbauer, S Hallek, M Benner, A Herling, M
Leukemia 29, 10October, 2015Pages: 2003-14doi: 10.1038/leu.2015.114ISSN: 1476-5551https://www.nature.com/articles/leu2015114/

Full text

News

New article accepted for publication

New article accepted for publication

August 30, 2020

Our work on T-PLL cells resembling the phenotype of activated memory-type effector T-cells has been accepted in Blood

Alkylating deacetylase inhibitor tinostamustine in T-PLL

March 11, 2020

New letter evaluating the effects of EDO-S101/tinostamustine published in Leukemia.

Advances and Perspectives in the Treatment of T-PLL

Advances and Perspectives in the Treatment of T-PLL

February 25, 2020

New review on current and future strategies in treating T-PLL published in Current Hematologic Malignancy Reports

JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

November 21, 2019

New meta-analysis on JAK/STAT genomic alterations in T-PLL published in Cancers.